Open AccessExperience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Author(s) -
Р. В. Роживанов
Publication year - 2012
Publication title -
ožirenie i metabolizm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.154
H-Index - 5
eISSN - 2306-5524
pISSN - 2071-8713
DOI - 10.14341/2071-8713-5123
Subject(s) - metabolic syndrome , testosterone (patch) , medicine , obesity , sexual function , endocrinology , sexual dysfunction , androgen , spermatogenesis , androgen deficiency , physiology , hormone
The article presents the results of clinical studies on the efficacy and safety of androgen therapy for metabolic syndrome and obesity in men with hypogonadism. The study is focused on the use of testosterone undecanoate for reduction of body fat and the severity of other components of the metabolic syndrome, improvement of sexual function without causing severe side effects. In a number of patients treated we observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.